Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rowe

Showing results (801-810 of 1,083) with videos related to

Pageof 109
Sort By:
Neurology|April 3, 2016
Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromesIan T S Coyle-Gilchrist, Katrina M Dick, Karalyn Patterson, et al.
Brain : a Journal of Neurology|March 1, 2014
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's diseaseZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Journal of Alzheimer'S Disease : JAD|August 12, 2017
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid BiomarkersIvan Koychev, Roger N Gunn, Azadeh Firouzian, et al.
Brain Communications|May 23, 2022
A data-driven model of brain volume changes in progressive supranuclear palsyW J Scotton, M Bocchetta, E Todd, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 6, 2019
ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathologyCarolin Koriath, Tammaryn Lashley, William Taylor, et al.
Human Brain Mapping|July 3, 2014
The default mode network is disrupted in Parkinson's disease with visual hallucinationsNailin Yao, Richard Shek-Kwan Chang, Charlton Cheung, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 15, 2019
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesEdwin Jabbari, John Woodside, Tong Guo, et al.
Neurobiology of Aging|July 15, 2020
Gray matter changes related to microglial activation in Alzheimer's diseaseNicolas Nicastro, Maura Malpetti, Elijah Mak, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 4, 2016
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's DiseaseRobin J Borchert, Timothy Rittman, Luca Passamonti, et al.
Cell Reports|February 20, 2026
Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathiesDorothea Böken, Melissa Huang, Yunzhao Wu, et al.
Pageof 109

Showing results (801-810 of 1,083) with videos related to

Sort By:
Pageof 109
Neurology|April 3, 2016
Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromesIan T S Coyle-Gilchrist, Katrina M Dick, Karalyn Patterson, et al.
Brain : a Journal of Neurology|March 1, 2014
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's diseaseZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Journal of Alzheimer'S Disease : JAD|August 12, 2017
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid BiomarkersIvan Koychev, Roger N Gunn, Azadeh Firouzian, et al.
Brain Communications|May 23, 2022
A data-driven model of brain volume changes in progressive supranuclear palsyW J Scotton, M Bocchetta, E Todd, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 6, 2019
ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathologyCarolin Koriath, Tammaryn Lashley, William Taylor, et al.
Human Brain Mapping|July 3, 2014
The default mode network is disrupted in Parkinson's disease with visual hallucinationsNailin Yao, Richard Shek-Kwan Chang, Charlton Cheung, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 15, 2019
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesEdwin Jabbari, John Woodside, Tong Guo, et al.
Neurobiology of Aging|July 15, 2020
Gray matter changes related to microglial activation in Alzheimer's diseaseNicolas Nicastro, Maura Malpetti, Elijah Mak, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 4, 2016
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's DiseaseRobin J Borchert, Timothy Rittman, Luca Passamonti, et al.
Cell Reports|February 20, 2026
Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathiesDorothea Böken, Melissa Huang, Yunzhao Wu, et al.
Pageof 109